Loading Events

« All Events

  • This event has passed.

Bill Sasse: An Insider’s Account of the Alzheimer’s Solanezumab Drug Trial

January 24 10:00 am 10:30 am PST

Bill Sasse

The process of finding new treatments for Alzheimer’s disease is one of trial and error — and every “failed” trial generates invaluable new data to help researchers and drug developers understand what works, what doesn’t, and why. On Wednesday, January 24th, at 10:00 a.m. PT/1:00 p.m. ET, drug trial participant Bill Sasse was a participant in Eli Lilly’s clinical trial of experimental monoclonal antibody drug solanezumab. In March of 2023, solanezumab ultimately failed to hit its benchmarks in slowing cognitive decline and the trial was discontinued.

Sasse, whose father died of Alzheimer’s, had the unique experience of participating in a clinical trial for a MAB drug without having any symptoms of cognitive decline. An army veteran, retired business owner, grandparent, and a native of Columbus, Indiana, he joined the trial after being inspired by a documentary about Glen Campbell promoting the trial, asking himself, “Why not, me?”

With his wife as his trial partner, he participated in the solanezumab trial for eight years before it was announced that the clinical trial had failed. He has participated in panels with Eli Lilly on his experience with the trial.

RSVP to learn more about the clinical trial experience with MAB drugs. 


January 24
10:00 am – 10:30 am PST


Being Patient

Being Patient Facebook Page

View Venue Website

Who's coming?

39 people are attending Bill Sasse: An Insider’s Account of the Alzheimer’s Solanezumab Drug Trial

4 thoughts on “Bill Sasse: An Insider’s Account of the Alzheimer’s Solanezumab Drug Trial

  1. I am interested in this medical trial. I am 72 yrs old. Healthy..
    My mother had Dementia. I worked in Homehealth Care for a number of years. I have seen families distroyed with this disease. I test anything to help with getting a drug approved

    1. Linda, thanks for reading, for sharing this, and especially, thank you for your work toward a better future for families navigating Alzheimer’s!

  2. My wife has Alzheimer’s for over 3 years. She is 74. This is the hardest job I have ever had being a caregiver. I tell people we have great days, and some days aren’t so great. I look forward everyday hoping a breakthrough will help the millions of people suffering with this terrible disease, and to the caregivers working 24/7. Thank you, Paul.

Leave a Reply

We are glad you have chosen to leave a comment. Please keep in mind that comments are moderated according to our comment policy.